EVO
Evotec SE ADR
NASDAQ: EVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.94
-1.34% today
Updated 2026-04-29
Market cap
$1.04B
P/E ratio
—
P/S ratio
1.33x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Evotec SE ADR (EVO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $186.11M | $205.53M | $207.88M | $182.90M | $146.60M | $191.86M | $218.21M | $225.43M | $227.38M | $224.60M | $288.54M | $351.37M | $667.27M | $771.88M | $1.38B | $1.84B | $2.24B | $2.26B | $2.30B | $1.91B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $81.97M | $113.82M | $111.84M | $93.08M | $68.96M | $86.69M | $83.33M | $88.10M | $122.53M | $125.30M | $166.94M | $169.24M | $180.25M | $249.77M | $527.05M | $806.13M | $1.10B | $1.07B | $903.16M | $681.96M |
| Total liabilities | $37.44M | $68.35M | $37.33M | $33.04M | $35.11M | $59.22M | $70.97M | $72.88M | $68.41M | $66.22M | $101.44M | $137.43M | $335.52M | $347.00M | $844.39M | $951.26M | $857.48M | $1.07B | $1.18B | $959.98M |
| Current liabilities | $29.67M | $55.48M | $24.34M | $21.83M | $26.45M | $32.80M | $42.83M | $33.88M | $38.95M | $33.07M | $56.40M | $73.39M | $245.78M | $196.28M | $200.88M | $255.06M | $324.52M | $337.71M | $464.57M | $344.58M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | $20.30M | $54.68M | $324.89M | $331.02M | $326.34M | $328.30M | $307.09M | $392.74M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-474.41M | $-506.88M | $-495.09M | $-573.38M | $-618.90M | $-615.64M | $-608.89M | $-606.42M | $-631.85M | $-638.83M | $-622.31M | $-592.93M | $-566.73M | $-481.01M | $-495.22M | $-529.36M | $-216.42M | $-392.38M | $-476.29M | $-672.37M |
| Accounts receivable | $14.13M | $7.77M | $9.17M | $3.90M | $4.86M | $12.44M | $10.59M | $15.53M | $18.21M | $26.15M | $22.19M | $29.83M | $69.98M | $60.94M | $139.34M | $167.48M | $176.75M | $275.77M | $204.06M | $218.38M |
| Inventory | $10.50M | $4.78M | $2.39M | $2.14M | $2.42M | $2.82M | $3.56M | $2.44M | $2.36M | $3.11M | $3.13M | $4.30M | $9.02M | $5.66M | $12.07M | $16.62M | $25.79M | $29.82M | $30.89M | $31.12M |
| Goodwill | — | $48.91M | $39.04M | $13.29M | $16.56M | $25.98M | $42.20M | $42.34M | $40.14M | $44.81M | $45.65M | $93.23M | $220.18M | $220.79M | $287.27M | $302.67M | $257.57M | $274.82M | $275.63M | $282.85M |